{
    "source": {
        "id": "business-insider",
        "name": "Business Insider"
    },
    "author": "Andrew Dunn",
    "title": "A buzzy Seattle biotech is teaming up with Microsoft and Amgen to hunt for 'the Michael Jordan of antibodies' to fight the coronavirus (AMGN, ADPT)",
    "description": "The Seattle biotech company Adaptive Biotechnologies has started research on a coronavirus therapeutic that could halt the spread of the virus. The small company has inked partnerships with industry behemoths to accelerate its work. It's working with Amgen, t\u2026",
    "url": "https://www.businessinsider.com/adaptive-biotechnologies-researches-coronavirus-antibodies-with-microsoft-amgen-2020-4",
    "urlToImage": "https://i.insider.com/5e975adf15ea4b6bf0259bd4?width=1200&format=jpeg",
    "publishedAt": "2020-04-15T19:05:00Z",
    "content": "To counter the coronavirus pandemic, drug companies are designing therapeutics to attack the virus.\r\nOne upstart biotech is hunting for \"the Michael Jordan of antibodies\" to turn into a coronavirus drug. Adaptive Biotechnologies recently teamed up with Amgen,\u2026 [+5314 chars]"
}